2023: Volume 5, Issue 1
Commentary P.1-2
Undifferentiated cell based Items in Medication: FDA Regulatory Considerations.
Author(s): Plave Tyi*
Mini Review P.1-2
Instigated Pluripotent Undifferentiated cells and Their True capacity for Essential and Clinical Sciences.
Author(s): Masato Nakagawa*
Short Communication P.1-2
Foundational cells microorganisms: past, present, and future.
Author(s): Leaoni Ric*